Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors-Reference-Cited by-同舟云学术

Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors

Published:2017-10-11 Issue:1 Volume:19 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Bernhardt Stephan^ORCID,Bayerlová Michaela,Vetter Martina,Wachter Astrid,Mitra Devina,Hanf Volker,Lantzsch Tilmann,Uleer Christoph,Peschel Susanne,John Jutta,Buchmann Jörg,Weigert Edith,Bürrig Karl-Friedrich,Thomssen Christoph,Korf Ulrike,Beissbarth Tim,Wiemann Stefan,Kantelhardt Eva Johanna

Funder

German Federal Ministry of Education and Research

Roux-Program of the Martin-Luther-University Halle-Wittenberg

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-017-0905-7.pdf

Reference54 articles.

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–386.

2. Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486:346–52.

3. Cancer Genome Atlas N. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490:61–70.

4. Weigelt B, Reis-Filho JS. Histological and molecular types of breast cancer: is there a unifying taxonomy? Nat Rev Clin Oncol. 2009;6:718–30.